Expanded Access to Everolimus, for an Individual Patient With Uterine

Updated 06/21/2024

Status Available

Clinical Trial Summary

Single patient treatment with everolimus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03493165
Study type	Expanded Access
Source	The University of Texas Health Science Center at San Antonio
Contact	John Sarantopoulos, MD
Phone	210-450-1785
Email	sarantopoulo@uthscsa.edu
Status	Available
Phase

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02096783` - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer	N/A
	Recruiting	`NCT00162721` - The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas	Phase 3
	Completed	`NCT01806350` - Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors	N/A
	Recruiting	`NCT05881967` - Molecular Mechanism Study of Uterine Sarcoma
	Active, not recruiting	`NCT06244251` - Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids	N/A
	Completed	`NCT00020267` - Vaccine Therapy in Treating Patients With Metastatic Cancer	Phase 1
	Recruiting	`NCT04224467` - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery	N/A
	Active, not recruiting	`NCT01979393` - IRCI Gynae Sarcomas, High Grade Uterine Sarcoma	Phase 2
	Completed	`NCT01303094` - Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma	Phase 2